| |
| |
|
| Insider
Information: |
Lundberg Magnus |
| Relationship: |
Director |
| City: |
Richmond |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Onyx Pharmaceuticals Inc |
ONXX |
Director |
2013-10-01 |
0 |
2003-12-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-10-01 |
4 |
D |
$125.00 |
$262,500 |
D/D |
(2,100) |
0 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-10-01 |
4 |
D |
$125.00 |
$1,514,500 |
D/D |
(12,116) |
2,100 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-04-11 |
4 |
AS |
$96.00 |
$960,000 |
D/D |
(10,000) |
14,216 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-04-11 |
4 |
OE |
$16.28 |
$162,800 |
D/D |
10,000 |
24,216 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-04-01 |
4 |
OE |
$23.70 |
$237,000 |
D/D |
10,000 |
24,216 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-04-01 |
4 |
AS |
$92.00 |
$920,000 |
D/D |
(10,000) |
14,216 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-03-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,100 |
14,216 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-03-11 |
4 |
AS |
$88.00 |
$440,000 |
D/D |
(5,000) |
12,116 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-03-11 |
4 |
OE |
$38.85 |
$194,250 |
D/D |
5,000 |
17,116 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2012-07-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,500 |
12,116 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2012-06-25 |
4 |
AS |
$65.18 |
$325,875 |
D/D |
(5,000) |
10,616 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2012-06-25 |
4 |
OE |
$12.11 |
$60,550 |
D/D |
5,000 |
15,616 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2012-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
10,616 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2011-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
7,616 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2010-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
4,616 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2010-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
3,616 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2009-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
1,616 |
1,616 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2004-06-15 |
4 |
S |
$40.33 |
$504,628 |
D/D |
(12,500) |
0 |
|
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2004-06-15 |
4 |
OE |
$6.01 |
$118,706 |
D/D |
12,500 |
12,500 |
|
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2003-12-29 |
4 |
S |
$28.50 |
$502,355 |
D/D |
(17,500) |
0 |
|
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2003-12-29 |
4 |
OE |
$12.06 |
$211,094 |
D/D |
17,500 |
17,500 |
|
- |
|
21 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
